Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

ICU Medical Inc. (ICUI)

NASDAQ: ICUI · Surgical & Medical Instruments & Apparatus · San Clemente, CA

Our rating: Cautious

Cautious reaffirmed at $182.11, moderate conviction, November 10, 2026.

Breaks if: Revenue returns to positive year-over-year growth in both of the next two quarterly filings AND annualized free cash flow reaches $130 million or above — if both conditions are met before mid-2027, the cautious view needs to be revisited. The stock trading and sustaining above $210 through the next two earnings prints, without a visible fundamental recovery, would equally challenge the thesis.

Key figures

Market value$4.3B
Revenue, last 12 months$2.2B
Net income, last 12 monthsn/a
Free cash flow, last 12 months$209M
Price to earningsn/a
Free cash flow yield4.8%
Dividend yield0.0%
Operating margin5.1%
Return on equityn/a
Beta to the S&P 5001.08
Volatility, annualized40.6%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$560M4.4%$1.07$83M
June 30, 2026$552M0.5%$0.76$62M
March 31, 2026$530M−12.3%$1.20$28M
December 31, 2025$541M−14.1%$-0.63$36M
September 30, 2025$537M−8.9%$-0.14$28M
June 30, 2025$549M−8.0%$1.43−$8M
March 31, 2025$605M6.7%$-0.63$37M
December 31, 2024$630M7.1%$-0.98$16M

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

10 ledger entries and 45 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.